ROLE OF GENETIC VARIABILITY IN METABOLIC PATHWAYS ON CISPLATIN-INDUCED KIDNEY INJURY IN HEAD AND NECK CANCER PATIENTS
Introduction/Justification: Head and neck squamous cell carcinoma (HNSCC) is a prevalent malignancy responsible for approximately 5.0% of global cancer deaths. The standard treatment for locally advanced HNSCC involves cisplatin (CDDP)-based chemotherapy and radiotherapy, which can lead to significa...
Saved in:
| Main Authors: | Ericka Francislaine Dias Costa, Ana Maria Castro Ferreira, Marilda Mazzali, Gustavo Jacob Lourenço, Carmen Silvia Passos Lima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925000355 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KIF13B C.*3163G>A SINGLE NUCLEOTIDE VARIANT ON OROPHARYNGEAL SQUAMOUS CELL CARCINOMA SUSCEPTIBILITY AND TUMOR CHARACTERISTICS
by: Ericka Francislaine Dias Costa, et al.
Published: (2025-05-01) -
Ototoxicity Monitoring: The Evolution of a Protocol for Head and Neck Cancer Patients
by: Jena Patel, et al.
Published: (2025-04-01) -
Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced head and neck squamous cell carcinoma: A real-world data study
by: Matheus Yung Perin, et al.
Published: (2025-05-01) -
Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma
by: Ankit P. Jain, et al.
Published: (2024-12-01) -
In vitro assay identifying cisplatin resistance of head and neck squamous cell carcinoma
by: Shu-Jen Chiang, et al.
Published: (2023-09-01)